HBIO · Harvard Bioscience, Inc.

Summary

Harvard Bioscience, Inc. filed an 8-K on March 10, 2026, disclosing under Item 5.02 an Amended and Restated Employment Agreement with John Duke and including Exhibit 10.1. This executive compensatory arrangement may impact leadership stability and officer incentives for investors.

Key takeaways

• Item 5.02: Compensatory Arrangements of Certain Officers
• Exhibit 10.1: Amended and Restated Employment Agreement
• Party: John Duke
• Company: Harvard Bioscience, Inc.
• Filing Date: 2026-03-10